Skip to main content

In vivo biodistribution study of TAT-L-Sco2 fusion protein, developed as protein therapeutic for mitochondrial disorders attributed to SCO2 mutations

G C Kaiafas, D Papagiannopoulou, Α N Miliotou, A S Tsingotjidou, P C Chalkidou, A C Tsika, G A Spyroulias, A S Tsiftsoglou, L C Papadopoulou. In vivo biodistribution study of TAT-L-Sco2 fusion protein, developed as protein therapeutic for mitochondrial disorders attributed to SCO2 mutations. Molecular Genetics and Metabolism Report, 25, 100683, (2020). doi: 10.1016/j.ymgmr.2020.100683